deltatrials
Completed NA NCT00408798

Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

Sponsor: University of British Columbia

Conditions Alopecia Areata
Interventions Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units
Updated 6 times since 2017 Last updated: Mar 1, 2017 Started: Oct 31, 2007 Primary completion: Oct 30, 2009 Completion: Oct 30, 2009

This NA trial investigates Alopecia Areata and is currently completed. University of British Columbia leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Mar 2017 — Jun 2018 [monthly]

    Completed NA

    Status: Unknown Status → Completed

▶ Show 1 earlier version

  1. Jan 2017 — Mar 2017 [monthly]

    Unknown Status NA

    First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of British Columbia
Data source: University of British Columbia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Vancouver, Canada